Roivant Sciences Ltd. (ROIV)
NASDAQ
36.54
+0.49 (+1.36%)
Delayed Data
Oct 27, 2026, 01:30 PM
Day's Range
35.8036.83
52 wk Range
18.2742.50
Financial Statements - ROIV - Roivant Sciences Ltd.
Revenue
8.26M▼ 71.6%
Net Income
-397.90M▼ 11.5%Net Margin -4817.3%
EBITDA
-2.16B▼ 71.0%
Free Cash Flow
-758.55M▲ 10.1%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 8.26M | 29.05M | 124.79M | 61.28M | 55.28M | 23.79M |
| Cost of Goods | 1.28M | 911K | 15.56M | 13.12M | 8.96M | 2.05M |
| Gross Profit | 6.97M | 28.14M | 109.23M | 48.15M | 46.32M | 21.73M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -1.28B | -1.11B | -1.07B | -1.07B | -1.21B | -474.76M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 842.61M | 173.71M | 5.22B | -151.48M | 294.67M | -422.39M |
| Pre Tax Income | -264.57M | -681.59M | 4.25B | -1.22B | -923.74M | -898.54M |
| Income Tax | 133.32M | 48.17M | 22.22M | 5.19M | 369K | 1.68M |
| Net Income | -397.90M | -356.73M | 4.23B | -1.11B | -924.11M | -900.23M |
| EPS Basic | -0.43 | -0.24 | 5.55 | -1.42 | -1.26 | -1.181727 |
| EPS Diluted | -0.54 | -0.24 | 5.23 | -1.42 | -1.26 | -1.181727 |
| Basic Shares Outstanding | 693.86M | 725.39M | 783.24M | 712.79M | 669.75M | 684.78M |
| Diluted Shares Outstanding | 693.86M | 725.39M | 783.24M | 712.79M | 669.75M | 684.78M |
| Ebit | -1.28B | -1.11B | 4.28B | -1.19B | -916.70M | -895.73M |
| Ebitda | -2.16B | -1.26B | -996.51M | -1.08B | -1.19B | -510.50M |
| Net Income Continuous Operations | -397.90M | -356.73M | 4.23B | -1.11B | -924.11M | -900.23M |
| Minority Interests | 98.13M | 184.75M | 117.72M | 106.43M | 78.85M | 90.99M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
